BioSpace News Archive

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended June 30, 2022.

Syros Pharmaceuticals announced the grant of a restricted stock unit award for 31,000 shares of Syros common stock to one newly hired employee in connection with the employee’s commencement of employment with Syros.

Legend Biotech Corporation announced the appointment of three new directors to its Board: Mr. Tomas Heyman as Class I director of Legend Biotech, Dr. Fangliang “Frank” Zhang as Class II director of Legend Biotech, and Dr. Li Mao as Class III director of Legend Biotech.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and second quarter 2022 financial results.

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2022 and provided a business update.

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the company will participate in Canaccord Genuity’s 42nd Annual Growth Conference on August 10th, 2022.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal third quarter ended June 30, 2022.

CareDx, Inc. reported financial results for the second quarter ended June 30, 2022.

A group of seasoned pharmaceutical industry veterans laid the foundation of AiViva Biopharma in 2015.

Generation Bio Co., a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and second quarter 2022 financial results.